Ischemia and stroke

Advances in Experimental Medicine and Biology

Volumn 513, Issue , 2002, Pages 455-473

  Endres, Matthias ^a   Dirnagl, Ulrich ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLTYROSYLVALYLALANYLASPARTYL CHLOROMETHYL KETONE; AMPA RECEPTOR; ARGININE; BETA INTERFERON; CASPASE 3; CASPASE INHIBITOR; DIZOCILPINE; GLUTAMATE RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ACIDOSIS; ANAEROBIC METABOLISM; ANOXIA; APOPTOSIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PERFUSION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CYTOTOXICITY; DEPOLARIZATION; ENERGY METABOLISM; EPIDEMIOLOGICAL DATA; GENE ACTIVATION; GLYCOLYSIS; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; PATHOPHYSIOLOGY; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; REVIEW; SODIUM CURRENT; STROKE; TEMPERATURE DEPENDENCE;

ACIDOSIS; ANIMALS; APOPTOSIS; BRAIN; BRAIN ISCHEMIA; CASPASES; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; NECROSIS; RECEPTORS, GLUTAMATE; TEMPERATURE;

EID: 0036944284     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (110)

1. Ginsberg MD. Animal models of global and focal cerebral ischemia. In: Welsh KMA, Caplan LC, Reis DJ, Siesjo BK, Weir B, eds. Primer on Cerebrovascular Disease. San Diego: Academic Press, 1997:124-126.
2. F ssler R, Martin K, Forsberg E et al. Knockout mice: how to make them and why. The immonological approach. Int Arch Allergy Immunol 1995; 196:323-334.
3. Majzoub JA, Muglia LJ. Knockout mice. N Engl J Med 1996; 334:904-907.
4. Rubin EM, Barsh GS. Biological insights through genomics: mouse to man. J Clin Invest 1996; 97:275-280.
5. Thomas KR. The knockout mouse: six yeras old and growing stronger. Am J Respir Cell Mol Biol 1995; 12:461-463.
6. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982; 11:491-498.
7. Fujii M, Hara H, Meng W et al. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and CC57/balck/6 mice. Stroke 1997; 28:1805-1811.
8. Tamura A, Graham DI, McCulloch J et al. Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60.
9. Tamura A, Graham DI, McCulloch J et al. Focal cerebral ischemia in the rat. 2. Regional cerebral bloow flow determined by [14C]iodoantopyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:61-69.
10. Belayev L, Busto R, Zhao W et al. HU-211, a novel noncompetitive N-methyl-D aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke 1995; 26:2313-2320.
11. Brint S, Jacewicz M, Kiessling M et al. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral artery and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 1988; 8:474-485.
12. Hara H, Huang PL, Panahian N et al. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 1996; 16:605-611.
13. Hallenbeck JM, Dutka AJ. Background review and current concept of reperfusion injury. Arch Neurol 1990; 47:1245-1254.
14. Ames A III, Wright RL, Kowada M et al. Cerebral ischemia 11. the no-reflow phenomenon. Am J Pathol 1968; 52:437-453.
15. Murakami K, Kondo T, Chan PH. Reperfusion following focal cerebral ischemia alters distribution of neuronal cells with DNA fragmentation in mice. Brain Res 1997; 751:160-164.
16. Leist M, Vollbracht C, K hnle S et al. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol Med 1997; 3:750-764.
17. Bonfoco E, Krainc D, Ankarcrona M et al. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995; 92:72162-72166.
18. Du C, Hu R, Csernansky CA, Hsu C et al. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Met 1996; 16:195-201.
19. Endres M, Namura S, Shimizu-Sasamata M et al. Attenuation of delayed neuronal death after mild focal cerebral ischemia in mice by inhibitors of the caspase family. J Cereb Blood Flow Metab 1998; 18:238-247.
20. Fink K, Zhu J, Namura S et al. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J Cereb Blood Flow Metab 1998; 18:1071-1076.
21. Dawson VL, Kizushi VM, Huang PL et al. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 1996; 16:2479-2487.
22. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984; 4:1884-1891.
23. Harms H, Wiegand F, Megow D et al. Acute treatment of hypertension increases infarct size in spontaneously hypertensive rats. Neuroreport 2000; 11:355-359.
24. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke. An integrated view. Trends Neurosci 1999; 22:391-397.
25. Martin RL, Lloyd HG, Cowan AI. The early events of oxygen and glucose deprivation: Setting the scence for neuronal death? Trends Neurosci 1994; 17:251-2578.
26. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opinion Neurobiol 1996; 8:667-672.
27. Chen H, Chopp MN, Vande Linde MQV et al. The effects of post-ischemic hypothermia on the neuronal injury and brain metabolism after forebrain ischemia in the rat. J Neurol Sci 1992; 107:191-198.
28. Furukawa K, Fu W, Li Y et al. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci 1997; 17:8178-8186.
29. Endres M, Fink KB, Zhu J et al. Neuroprotective effects of gelsolin during murine stroke. J Clin Invest 1999; 103:347-354.
30. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1997; 271:C1424-1437.
31. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997; 1997; 20:132-139.
32. Dalkara T, Moskowitz MA. The complex role ot nitric oxide in the pathophysiology of focal cerebral ischemia. Brain Pathol 1994; 4:49-57.
33. Zhang J, Dawson VL, Dawson TM. Nitric oxide activation of poly(ADP-ribose)synthetease in neurotoxicity. Science 1994; 263:687-689.
34. Szabo C, Zingarelli B, O«Connor M et al. DNA strand breakage, activation of poly(ADP-ribose)synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci 1996; 93:1753-1758.
35. Endres M, Wang Z-Q, Namura S et al. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blod Flow Metab 1997; 17:1143-1151.
36. Eliasson MJL, Sampei K, Mandir AS et al. Poly(ADP-ribose)polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med 1997; 3:1089-1095.
37. Endres M, Scott GS, Namura S et al. Role of perosynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose)synthetase, against peroxynitrite-induced glial damage and stroke development. Neurosci Lett 1998; 248:41-44.
38. Huang PL, Huang Z, Mashimo H et al. Hypertension in mice lacking the gene for endothelial nitric oxide snythase. Nature 1995; 377:239-242.
39. Huang Z, Huang PL, Ma J et al. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb. Blood Flow Metab 1996; 16:981-987.
40. Endres M, Laufs U, Huang Z. Stroke protection by 3-hydroxy-3 methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide snythase. Proc Natl Acad Sci USA 1998; 95:8880-8885.
41. Laufs U, Gertz K, Huang PL et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from stroke in normocholesterolemic mice. Stroke 31:2437-2449.
42. Dugan LL, Choi DW. Excitotoxicity, free radicals, and cell membrane changes. Ann Neurol 1994; 35 Suppl:S17-21.
43. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke 1998; 29:705-718.
44. Fujimura M, Morita-Fujimura Y, Murakami K et al. Cytosolic redristribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1998; 18:1239-1247.
45. Siesj BK, Kristian T, Katsura. In: Ginsberg MD, Bogousslavsky J, Eds. Cerebrovascular Disease. Blackwell Science, 1998:1-13.
46. Hossmann KA. Periinfarct depolarizations. Cerebrovasc Brain Metab Rev 1996; 8:195-208.
47. Obrenovitch TP. The ischaemic penumbra: Twenty years on. Cerebrovasc Brain Metab Rev 1995; 7:297-323.
48. Astrup J,Siesjo BK, Symon L. Thresholds in cerebral ischemia The ischemic penumbra. Stroke 1981; 12:723-725.
49. Furlan M, Marchal G, Viader F et al. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996; 40:216-226.
50. Read SJ, Hirano T, Abbott DF et al. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology 1998; 51:1617-1621.
51. Kaufmann AM, Firlik AD, Fukui MB et al. Ischemic core and penumbra in human stroke. Stroke 1999; 30:93-99.
52. Deutsch SI, Huntzinger JA, Rosse RB et al. The role of excitatory amino acids and intraneuronal calcium in the acute intoxicational effects of ethanol. Clin Neuropharmacol 1989; 12:1-13.
53. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244:1360-1362.
54. Turski L, Huth A, Sheardown M et al. ZK20075: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci USA 1998; 95:10960-10965.
55. Bond A, O«Neill MJ, Hicks et al. Neuroprotective effects of a systemically active group II metabotropic glutatmate receptor agonist LY354740 in a gerbil model of global ischemia. Neuroreport 1998; 9:1191-1193.
56. Nedergaard M, Hansen AJ. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J Cereb Blood Flow Metab 1993; 13:568-574.
57. Haring HP, Berg EL, Tsurushita N et al. E-selectin apperas in nonischemic tissue during experimental focal ischemia. Stroke 1996; 27:1386-1391.
58. Mies G, Iijima T, Hossmann KA. Correlation between peri-infarct DC shift and ischaemic neuronal damage in rat. NeuroReport 1993; 4:709-711.
59. Iijima T, Mies G, Hossmann KA. Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: Effect on volume of ischemic injury. J Cereb Blood Flow Metab 1992; 12:727-733.
60. Back T, Hirsch JG, Szabo K et al. Failure to demonstrate peri-infarct depolarizations by repetitive MR diffusion imaging in acute human stroke. Stroke 2000; 31:2901-2906.
61. O Neill LA, Kaltschmidt . NF-kappa B: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997; 20:252-258.
62. Ruscher K, Isaev N, Trendelenburg G et al. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett 1998; 254:117-120.
63. Iadecola C, Zhan F, Casey R et al. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17:9157-9164.
64. Lindsberg PJ, Carpen O, Paetau A et al. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996, 94:939-945.
65. Pirttil TR, Kauppinen RA. Recovery of intracellular pH in cortical brain slices following anoxia studied by nuclear magnetic resonance spectroscopy: Role of lactate removal, extracellular sodium and sodium/hydrogen exchange. Neurosci 1992; 47:155-164.
66. Gong C, Qin Z, Betz AL et al. Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice. Brain Res 1998; 801:1-8.
67. Feuerstein GZ, Wang X, Barone FC. Pathophysiology, diagnosis and management. In: Ginsberg MD, Bogousslavsky J, Eds. Cerebrovascular Disease. Malden: Blackwell Science, 1998:507-531.
68. Chopp M, Li Y, Jiang N et al. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 1996; 16:578-584.
69. Dereski MO, Chopp M, Knight et al. the heterogenous evolution of focal ischemic neuronal damage in the rat. Acta Neuropathologica Berl 1993; 85:327-333.
70. Baird AE, Benfield A, Schlaug G et al. Enlargment of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997; 41:581-589.
71. Iadecola C, Niwa K, Nogawa S et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 2001; 98:1294-1299.
72. Barone FC Arvin B, White RF et al. Tumor necrosis factor-alpha. a mediator of focal ischemic brain injury. Stroke 1997; 28:1233-1244.
73. Bruce AJ, Boling W, Kindy MS et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996; 2:788-794.
74. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenen with wide-ranging implication in tissue kinetics. Br J Cancer 1972; 26:239.
75. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993; 24:2002-2009.
76. Tominaga T, Kure S, Narisawa K et al. Endonuclease activation following focal ischemic injury in the rat. Brain Res 1993; 608:21-26.
77. MacManus JP, Buchan AM, Hill IE et al. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett 1993; 164:89-92.
78. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146:3-15.
79. MacManus JP, Hill IE, Huang ZG et al. DNA damage consistent with apoptosis in transient focal ischaemic cortex. NeuroReport 1994; 5:493-496.
80. MacManus JP, Hill IE, Preston E et al. Differences in DNA fragmentation following transient cerebral or decapitation ischemia in rats. J Cereb Blood Flow Metab 1995; 15:728-737.
81. Charriaut-Marlangue C, Margaill I, Plotkine M et al. Early endonuclease activation following reversible focal ischemia in the rat brain. J Cereb Blood Flow Metab 1995; 15:385-388.
82. Charriaut-Marlangue C, Margaill I, Represa A et al. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J Cereb Blood Flow Met 1996; 16:186-194.
83. Li Y, Chopp M, Jiang N et al. In situ detection of DNA fragmentation after focal cerebral ischemia in mice. Mol Brain Res 1995; 28:164-168.
84. Li Y, Chopp M, Jiang N et al. Induction of DNA fragmentation after 10 to 120 min of focal cerebral ischemia in rats. Stroke 1995; 26:1252-1258.
85. van Lookeren Campagne M, Gill R. Ultrastructural morphological changes are not characteristic of apoptototic cell death following focal cerebral ischaemia in the rat. Neurosci Lett 1996; 213:111-114.
86. Ameisen JC. The origin of programmed cell death. Science1996; 27:1278-1279.
87. Bredesen DE (1995) Neural apoptosis. Ann Neurol 1995; 38:839-851.
88. Hockenberry D. Defining apoptosis. Am J Pathol 1995; 146:16-19.
89. Raff MC, Barres BA, Burne JF et al. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 1993; 262:695-700.
90. Chinaiyan Am, O Rourke K, Lane Bret al. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 1997; 275:1122-1126.
91. Ellis HM, Horvitz HR. Genetic control of programmmed cell death in the nematode C. elegans. Cell 1986; 44:817-829.
92. Ellis HM, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991; 7:663-698.
93. Wu DG, Wallen WD, Nunez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 1997; 275:1126-1129.
94. Yuan J, Shaham S, Ledoux S et al.The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75:641-652.
95. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomenclature Cell 1996; 87:1712.
96. Redd CJ. Cytochrome c: Can t live it Can t live without it. Cell 1997; 91:559-562.
97. Namura S, Zhu J, Fink K et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998; 18:3659-3668.
98. Friedlander RM, Gagliardini V, Hara H et al. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 1997; 185:933-940.
99. Schielke GP, Yang GY, Shivers BD et al. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998; 18:180-185.
100. Hara H, Friedlander RM, Gagliardini V et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94:2007-2012.
101. Shaw E. Cysteinyl proteinases and their selective inactivation. Adv Enzymol Relat Areas Mol Biol 1990; 63:271-347.
102. Sarin A, Wu ML, Henkart P. Different interleukin-1 beta converting enzyme family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med 1996; 184:2445-2450.
103. Nicholson WD, Ali A, Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature 1995; 376:37-43.
104. Nicholson WD, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997; 22:299-306.
105. Chen J, Nagayama T, Jin K et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18:4914-4928.
106. Cheng Y, Deskmukh M, D-Costa A et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101:1992-1999.
107. Ma J, Endres M, Moskowitz MA. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. Br J Pharmacol 1998; 124:756-762.
108. Minamisawa H, Mellergard P, Smith ML et al. Preservation of brain temperature during ischemia in rats. J Cereb Blood Flow Metab 1990; 10:365-374.
109. Busto R, Globus MYT, Dietrich D et al. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987; 7:729-738.
110. Crumrine RC, LaManna JC. Regional cerebral metabolites, blood flow, plasma volume, and mean transit time in total cerebral ischemia in the rat. J Cereb Blood Flow Metab 1991; 11:272-282.